These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 8868343)

  • 21. Gene therapy progress and prospects: cystic fibrosis.
    Griesenbach U; Ferrari S; Geddes DM; Alton EW
    Gene Ther; 2002 Oct; 9(20):1344-50. PubMed ID: 12364999
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene therapy for cystic fibrosis: perspectives for the otolaryngologist.
    Graham SM
    Clin Otolaryngol Allied Sci; 1998 Dec; 23(6):481-3. PubMed ID: 9884799
    [No Abstract]   [Full Text] [Related]  

  • 23. Reversal of cystic fibrosis phenotype in mice by gene therapy in utero.
    Larson JE; Morrow SL; Happel L; Sharp JF; Cohen JC
    Lancet; 1997 Mar; 349(9052):619-20. PubMed ID: 9057739
    [No Abstract]   [Full Text] [Related]  

  • 24. A phase I study of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator gene to a lung segment of individuals with cystic fibrosis.
    Zuckerman JB; Robinson CB; McCoy KS; Shell R; Sferra TJ; Chirmule N; Magosin SA; Propert KJ; Brown-Parr EC; Hughes JV; Tazelaar J; Baker C; Goldman MJ; Wilson JM
    Hum Gene Ther; 1999 Dec; 10(18):2973-85. PubMed ID: 10609658
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In utero efficacy of cystic fibrosis gene therapy: difficult studies, positive or negative.
    Flotte TR
    Mol Ther; 2008 May; 16(5):806-7. PubMed ID: 18432269
    [No Abstract]   [Full Text] [Related]  

  • 26. Vector-specific complementation profiles of two independent primary defects in cystic fibrosis airways.
    Zhang Y; Jiang Q; Dudus L; Yankaskas JR; Engelhardt JF
    Hum Gene Ther; 1998 Mar; 9(5):635-48. PubMed ID: 9551612
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis.
    Zabner J; Couture LA; Gregory RJ; Graham SM; Smith AE; Welsh MJ
    Cell; 1993 Oct; 75(2):207-16. PubMed ID: 7691415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Gene therapy of cystic fibrosis; review of completed clinical studies].
    Coutelle C; Bigger B
    Internist (Berl); 2001 Oct; 42(10):1346-50, 1353-6. PubMed ID: 11688153
    [No Abstract]   [Full Text] [Related]  

  • 29. Gene Therapy for Cystic Fibrosis Paved the Way for the Use of Adeno-Associated Virus in Gene Therapy.
    Guggino WB; Cebotaru L
    Hum Gene Ther; 2020 May; 31(9-10):538-541. PubMed ID: 32283956
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A step towards gene therapy for CF.
    Sansom C
    Mol Med Today; 1999 Jul; 5(7):279. PubMed ID: 10377513
    [No Abstract]   [Full Text] [Related]  

  • 31. [On the way to gene therapy in cystic fibrosis].
    Norek A; Bal J
    Med Wieku Rozwoj; 2006; 10(1 Pt 2):247-74. PubMed ID: 17028392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene therapy for cystic fibrosis.
    Davies JC; Geddes DM; Alton EW
    J Gene Med; 2001; 3(5):409-17. PubMed ID: 11601754
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Repeat administration of an adenovirus vector encoding cystic fibrosis transmembrane conductance regulator to the nasal epithelium of patients with cystic fibrosis.
    Zabner J; Ramsey BW; Meeker DP; Aitken ML; Balfour RP; Gibson RL; Launspach J; Moscicki RA; Richards SM; Standaert TA
    J Clin Invest; 1996 Mar; 97(6):1504-11. PubMed ID: 8617884
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genomic context vectors and artificial chromosomes for cystic fibrosis gene therapy.
    Conese M; Boyd AC; Di Gioia S; Auriche C; Ascenzioni F
    Curr Gene Ther; 2007 Jun; 7(3):175-87. PubMed ID: 17584036
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Gene therapy: development of adenovirus vectors].
    Siegfried W
    Pneumologie; 1996 Dec; 50 Suppl 3():860-4. PubMed ID: 9157443
    [No Abstract]   [Full Text] [Related]  

  • 36. Gene transfer to freshly isolated human respiratory epithelial cells in vitro using a replication-deficient adenovirus containing the human cystic fibrosis transmembrane conductance regulator cDNA.
    Rosenfeld MA; Chu CS; Seth P; Danel C; Banks T; Yoneyama K; Yoshimura K; Crystal RG
    Hum Gene Ther; 1994 Mar; 5(3):331-42. PubMed ID: 7517189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prospects for gene therapy in cystic fibrosis.
    Jaffé A; Bush A; Geddes DM; Alton EW
    Arch Dis Child; 1999 Mar; 80(3):286-9. PubMed ID: 10325715
    [No Abstract]   [Full Text] [Related]  

  • 38. Utility of the nasal model in gene transfer studies in cystic fibrosis.
    Graham SM; Launspach JL
    Rhinology; 1997 Dec; 35(4):149-53. PubMed ID: 9532632
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Status of gene therapy for cystic fibrosis lung disease.
    Boucher RC
    J Clin Invest; 1999 Feb; 103(4):441-5. PubMed ID: 10021450
    [No Abstract]   [Full Text] [Related]  

  • 40. Topical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis-related lung disease.
    Lee T; Southern KW
    Cochrane Database Syst Rev; 2007 Apr; (2):CD005599. PubMed ID: 17443603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.